Bococizumab is a cutting-edge anti-PCSK9 antibody efficiently developed to treat hypercholesterolemia. This therapeutic agent interacts with the PCSK9 protein, a key regulator of cholesterol levels. By neutralizing the https://zaynnogt779986.wikiinside.com/3762386/bococizumab_a_novel_anti_pcsk9_antibody_for_hypercholesterolemia